[HTML][HTML] Lipid alterations in chronic liver disease and liver cancer
B Paul, M Lewinska, JB Andersen - JHEP reports, 2022 - Elsevier
Lipids are a complex and diverse group of molecules with crucial roles in many
physiological processes, as well as in the onset, progression, and maintenance of cancers …
physiological processes, as well as in the onset, progression, and maintenance of cancers …
Metabolic rearrangements in primary liver cancers: cause and consequences
L Satriano, M Lewinska, PM Rodrigues… - Nature reviews …, 2019 - nature.com
Primary liver cancer (PLC) is the fourth most frequent cause of cancer-related death. The
high mortality rates arise from late diagnosis and the limited accuracy of diagnostic and …
high mortality rates arise from late diagnosis and the limited accuracy of diagnostic and …
Rapid, label-free histopathological diagnosis of liver cancer based on Raman spectroscopy and deep learning
L Huang, H Sun, L Sun, K Shi, Y Chen, X Ren… - Nature …, 2023 - nature.com
Biopsy is the recommended standard for pathological diagnosis of liver carcinoma.
However, this method usually requires sectioning and staining, and well-trained pathologists …
However, this method usually requires sectioning and staining, and well-trained pathologists …
USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma
Z Ning, X Guo, X Liu, C Lu, A Wang, X Wang… - Nature …, 2022 - nature.com
Elevated de novo lipogenesis is considered to be a crucial factor in hepatocellular
carcinoma (HCC) development. Herein, we identify ubiquitin-specific protease 22 (USP22) …
carcinoma (HCC) development. Herein, we identify ubiquitin-specific protease 22 (USP22) …
An integrated metabolic atlas of clear cell renal cell carcinoma
Dysregulated metabolism is a hallmark of cancer, manifested through alterations in
metabolites. We performed metabolomic profiling on 138 matched clear cell renal cell …
metabolites. We performed metabolomic profiling on 138 matched clear cell renal cell …
[PDF][PDF] A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma
P Luo, P Yin, R Hua, Y Tan, Z Li, G Qiu, Z Yin… - …, 2018 - Wiley Online Library
Hepatocellular carcinoma (HCC) is the third most lethal cancer worldwide. The lack of
effective biomarkers for the early detection of HCC results in unsatisfactory curative …
effective biomarkers for the early detection of HCC results in unsatisfactory curative …
PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma
K Wang, L Luo, S Fu, M Wang, Z Wang, L Dong… - Nature …, 2023 - nature.com
Serine synthesis is crucial for tumor growth and survival, but its regulatory mechanism in
cancer remains elusive. Here, using integrative metabolomics and transcriptomics analyses …
cancer remains elusive. Here, using integrative metabolomics and transcriptomics analyses …
Metabolomics for laboratory diagnostics
R Bujak, W Struck-Lewicka, MJ Markuszewski… - … of pharmaceutical and …, 2015 - Elsevier
Metabolomics is an emerging approach in a systems biology field. Due to continuous
development in advanced analytical techniques and in bioinformatics, metabolomics has …
development in advanced analytical techniques and in bioinformatics, metabolomics has …
Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators
E Piccinin, G Villani, A Moschetta - Nature reviews Gastroenterology & …, 2019 - nature.com
Alterations of hepatic metabolism are critical to the development of liver disease. The
peroxisome proliferator-activated receptor-γ coactivators (PGC1s) are able to orchestrate, on …
peroxisome proliferator-activated receptor-γ coactivators (PGC1s) are able to orchestrate, on …
[PDF][PDF] 我国肝癌研究的现状与前景
吕桂帅, 陈磊, 王红阳 - 生命科学, 2015 - lifescience.sinh.ac.cn
肝癌是病死率最高的恶性肿瘤之一. 我国每年约有38.3 万人死于肝癌, 占全球肝癌死亡病例数的
51%, 严峻的形势给我国的社会和医疗带来了沉重的负担. 不断增加的科研经费投入为我国肝癌 …
51%, 严峻的形势给我国的社会和医疗带来了沉重的负担. 不断增加的科研经费投入为我国肝癌 …